[Reversibility of cognitive disorders among chronic alcoholics in phases of withdrawal. Effect of arginine pyroglutamate].
D000328:Adult; D000368:Aged; D000437:Alcoholism / Q000150:complications*; D002986:Clinical Trials as Topic; D003072:Cognition Disorders / Q000188:drug therapy*; D004151:Dipeptides / Q000627:therapeutic use*; D000431:Ethanol / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D011761:Pyrrolidonecarboxylic Acid / Q000031:analogs & derivatives; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*
D004151:Dipeptides; D000431:Ethanol; C048136:arginylpyroglutamate; D011761:Pyrrolidonecarboxylic Acid
Sulla reversibilità dei disordini cognitivi negli alcoolisti cronici in fase di disassuefazione. Effetti del piroglutammato di arginina.